Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.29 USD | +2.39% | +6.72% | -33.39% |
Financials (USD)
Sales 2024 * | 18.89M | Sales 2025 * | 73.35M | Capitalization | 1.14B |
---|---|---|---|---|---|
Net income 2024 * | -185M | Net income 2025 * | -136M | EV / Sales 2024 * | 27.1 x |
Net cash position 2024 * | 629M | Net cash position 2025 * | 542M | EV / Sales 2025 * | 8.17 x |
P/E ratio 2024 * |
-5.75
x | P/E ratio 2025 * |
-7.85
x | Employees | 467 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 3.32% |
Latest transcript on Autolus Therapeutics plc
1 day | +2.39% | ||
1 week | +6.72% | ||
Current month | +2.39% | ||
1 month | +2.39% | ||
3 months | -24.74% | ||
6 months | +6.98% | ||
Current year | -33.39% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 14-08-31 |
Christian Itin
CEO | Chief Executive Officer | 59 | 14-09-30 |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 14-07-31 |
William Young
BRD | Director/Board Member | 79 | 21-11-14 |
Cynthia Butitta
BRD | Director/Board Member | 69 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 4.29 | +2.39% | 1,528,158 |
24-06-04 | 4.19 | -6.89% | 1,884,490 |
24-06-03 | 4.5 | +7.40% | 1,425,194 |
24-05-31 | 4.19 | +5.01% | 1,494,830 |
24-05-30 | 3.99 | -0.75% | 885,826 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.39% | 1.14B | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.60% | 22.67B | |
-9.70% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- AUTL Stock